Broad Institute: Study Reveals How Cancer Immunotherapy May Cause Heart Inflammation in Some Patients
November 07, 2024
November 07, 2024
CAMBRIDGE, Massachusetts, Nov. 7 (TNSres) -- The Broad Institute issued the following news:
* * *
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
* * *
By Leah Eisenstadt
Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflamm . . .
* * *
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
* * *
By Leah Eisenstadt
Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflamm . . .